Literature DB >> 3356900

Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin.

M C Sirianni1, S Soddu, W Malorni, G Arancia, F Aiuti, S Soddus.   

Abstract

Previous studies have demonstrated the importance of some cytoskeleton components in killing mechanisms. In fact, a microtubule and microfilament (MF) rearrangement in the lytic sequence of CTL and NK cells has been observed. In particular, MF seem to be related to the binding phase, because MF inhibitors suppress the binding of NK cells to the target, whereas microtubule inhibitors suppress only the killing phase. In this paper, the distribution of two cytoskeleton components, actin and alpha- and beta-tubulin, has been studied in PBL from AIDS patients, who maintain the capacity to bind to the target cell line K562 but are not able to kill it. PBL were labeled with mAb to these two cytoskeleton components, and then indirect immunofluorescence was used to visualize their distribution in the conjugates. A normal polarization of actin in the effector PBL was found, whereas no tubulin rearrangement was evident in the effector and target cells. On the contrary, in conjugates of PBL or large granular lymphocytes from normal donors and K562, a polarization of actin in the effector cell and a polarization of tubulin both in the effector and in the target cells, at the site of the attachment, was evident. These data suggest that a deficiency of tubulin rearrangement may underlie the inability of the NK cells from AIDS patients to kill their target.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3356900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.

Authors:  J Chehimi; S Bandyopadhyay; K Prakash; B Perussia; N F Hassan; H Kawashima; D Campbell; J Kornbluth; S E Starr
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  Responses of murine natural killer cells to binding of the fungal target Cryptococcus neoformans.

Authors:  M R Hidore; T W Mislan; J W Murphy
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

3.  Deficient antibody-dependent cellular cytotoxicity against human immunodeficiency virus (HIV)-expressing target cells in perinatal HIV infection.

Authors:  U Ziegner; D Campbell; K Weinhold; I Frank; R Rutstein; S E Starr
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

4.  Redox imbalance and immune functions: opposite effects of oxidized low-density lipoproteins and N-acetylcysteine.

Authors:  M Viora; M G Quaranta; E Straface; R Vari; R Masella; W Malorni
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

5.  Changes in natural immunity during the course of HIV-1 infection.

Authors:  B G Brenner; C Gryllis; M Gornitsky; M A Wainberg
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals.

Authors:  C Gryllis; M A Wainberg; Z Bentwich; M Gornitsky; B G Brenner
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 7.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

8.  Natural killer (NK) cell activity during HIV infection: a decrease in NK activity is observed at the clonal level and is not restored after in vitro long-term culture of NK cells.

Authors:  D Scott-Algara; F Vuillier; A Cayota; G Dighiero
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

9.  Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS.

Authors:  B G Brenner; M Gornitsky; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

10.  Defective natural immunity: an early manifestation of human immunodeficiency virus infection.

Authors:  H Ullum; P C Gøtzsche; J Victor; E Dickmeiss; P Skinhøj; B K Pedersen
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.